Volume 98 Number 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Antibiotic resistance is not solely a medical but also a social problem, influenced partly by patients’ treatment-seeking behavior and their conceptions of illness and medicines. Situated within the context of a clinical trial of C-reactive protein (CRP) biomarker testing to reduce antibiotic over-prescription at the primary care level, our study explores and compares the narratives of 58 fever patients in Chiang Rai (Thailand) and Yangon (Myanmar). Our objectives are to 1) compare local conceptions of illness and medicines in relation to health-care seeking and antibiotic demand; and to 2) understand how these conceptions could influence CRP point-of-care testing (POCT) at the primary care level in low- and middle-income country settings. We thereby go beyond the current knowledge about antimicrobial resistance and CRP POCT, which consists primarily of clinical research and quantitative data. We find that CRP POCT in Chiang Rai and Yangon interacted with fever patients’ preexisting conceptions of illness and medicines, their treatment-seeking behavior, and their health-care experiences, which has led to new interpretations of the test, potentially unforeseen exclusion patterns, implications for patients’ self-assessed illness severity, and an increase in the status of the formal health-care facilities that provide the test. Although we expected that local conceptions of illness diverge from inbuilt assumptions of clinical interventions, we conclude that this mismatch can undermine the intervention and potentially reproduce problematic equity patterns among CRP POCT users and nonusers. As a partial solution, implementers may consider applying the test after clinical examination to validate rather than direct prescription processes.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S, , 2011. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 11: 692701.
  2. Reardon S, , 2015. Dramatic Rise Seen in Antibiotic Use. Nature News. Available at: https://www.nature.com/news/dramatic-rise-seen-in-antibiotic-use-1.18383. Accessed August 5, 2017.
  3. Toner E, Adalja A, Gronvall GK, Cicero A, Inglesby TV, , 2015. Antimicrobial resistance is a global health emergency. Health Secur 13: 153155.
  4. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, Pablos-Mendez A, Klugman KP, , 2005. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5: 481493.
  5. Ayukekbong JA, Ntemgwa M, Atabe AN, , 2017. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 6: 47.
  6. Chandler C, Hutchinson E, Hutchison C, , 2016. Addressing Antimicrobial Resistance through Social Theory: An Anthropologically Oriented Report. London, United Kingdom: London School of Hygiene and Tropical Medicine.
  7. Smith R, , 2015. Antimicrobial resistance is a social problem requiring a social solution. BMJ 350: h2682.
  8. Elsevier BV, , 2017. Scopus. Available at: https://www.scopus.com. Accessed July 31, 2017.
  9. Hildenwall H, Muro F, Jansson J, Mtove G, Reyburn H, Amos B, , 2017. Point‐of‐care assessment of C‐reactive protein and white blood cell count to identify bacterial aetiologies in malaria‐negative paediatric fevers in Tanzania. Trop Med Int Health 22: 286293.
  10. Huang Y, Chen R, Wu T, Wei X, Guo A, , 2013. Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract 63: e787e794.
  11. Lubell Y, 2015. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in southeast Asia. BMC Infect Dis 15: 511.
  12. Gelband H, Laxminarayan R, , 2015. Tackling antimicrobial resistance at global and local scales. Trends Microbiol 23: 524526.
  13. Hopkins H, 2017. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ 356: j1054.
  14. Beisel U, Umlauf R, Hutchinson E, Chandler CI, , 2016. The complexities of simple technologies: re-imagining the role of rapid diagnostic tests in malaria control efforts. Malar J 15: 64.
  15. Burchett HE, 2017. Improving prescribing practices with rapid diagnostic tests (RDTs): synthesis of 10 studies to explore reasons for variation in malaria RDT uptake and adherence. BMJ Open 7: e012973.
  16. Hutchinson E, Hutchison C, Lal S, Hansen K, Kayendeke M, Nabirye C, Magnussen P, Clarke SE, Mbonye A, Chandler CI, , 2017. Introducing rapid tests for malaria into the retail sector: what are the unintended consequences? BMJ Glob Health 2: e000067.
  17. Feierman S, , 1981. Therapy as a system-in-action in northeastern Tanzania. Soc Sci Med 15: 353360.
  18. Whyte SR, Van der Geest S, Hardon A, , 2002. Social Lives of Medicines. Cambridge, United Kingdom: Cambridge University Press.
  19. Beals AR, , 1976. Strategies of resort to curers in south India. Leslie CM, ed. Asian Medical Systems: A Comparative Study. Berkeley, CA: University of California Press, 184–200.
  20. Kibadi K, Boelaert M, Kayinua M, Minuku J, Muyembe‐Tamfum J, Portaels F, Lefevre P, , 2009. Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo. Trop Med Int Health 14: 11101116.
  21. Nyamongo I, , 2002. Health care switching behaviour of malaria patients in a Kenyan rural community. Soc Sci Med 54: 377386.
  22. Samuelsen H, , 2004. Therapeutic itineraries: the medical field in rural Burkina Faso. Anthropol Med 11: 2741.
  23. Bjerrum L, Gahrn-Hansen B, Munck AP, , 2004. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 54: 659662.
  24. Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ, , 2009. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 338: b1374.
  25. Jakobsen KA, Melbye H, Kelly MJ, Ceynowa C, Mölstad S, Hood K, Butler CC, , 2010. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care 28: 229236.
  26. Do TTN, , 2017. Assessing and Improving Rational Antimicrobial Use in Urban and Rural Health Care Facilities in Vietnam. PhD Thesis, Open University, Milton Keynes, United Kingdom. Available at: http://oro.open.ac.uk/id/eprint/48946.
  27. Anthierens S, GRACE/CHAMP INTRO Team , 2015. Clinicians’ views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections. J Gen Intern Med 30: 408416.
  28. Bustinduy AL, Jeyaratnam D, Douthwaite S, Tonkin‐Crine S, Shaw R, Hyrapetian L, Sevdalis N, Goldenberg S, Adams E, Sharland M, CLAHRC South London Paediatric Infection Network; ; , 2017. Point‐of‐care tests for infectious diseases: barriers to implementation across three London teaching hospitals. Acta Paediatr 106: 11921195.
  29. Hardy V, Thompson M, Keppel GA, Alto W, Dirac MA, Neher J, Sanford C, Hornecker J, Cole A, , 2017. Qualitative study of primary care clinicians’ views on point-of-care testing for C-reactive protein for acute respiratory tract infections in family medicine. BMJ Open 7: e012503.
  30. Van den Bruel A, Jones C, Thompson M, Mant D, , 2016. C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Arch Dis Child 101: 382385.
  31. Wood F, 2011. A multi-country qualitative study of clinicians’ and patients’ views on point of care tests for lower respiratory tract infection. Fam Pract 28: 661669.
  32. Huddy JR, Ni MZ, Barlow J, Majeed A, Hanna GB, , 2016. Point-of-care C reactive protein for the diagnosis of lower respiratory tract infection in NHS primary care: a qualitative study of barriers and facilitators to adoption. BMJ Open 6: e009959.
  33. WHO, 2013. Emergency Response to Artemisinin Resistance in the Greater Mekong Subregion: Regional Framework for Action 2013–2015. Geneva, Switzerland: World Health Organization.
  34. Chereau F, Opatowski L, Tourdjman M, Vong S, , 2017. Risk assessment for antibiotic resistance in south east Asia. BMJ 358: j3393.
  35. Valvatne H, Syre H, Kross M, Stavrum R, Ti T, Phyu S, Grewal HM, , 2009. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. J Antimicrob Chemother 64: 694701.
  36. Watt G, 1996. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet 348: 8689.
  37. Angrosino M, , 2007. Doing Ethnographic and Observational Research. Los Angeles, CA: Sage.
  38. Ayres L, , 2008. Thematic coding and analysis. Lewis-Beck MS, Bryman A, Liao TF, eds. The SAGE Encyclopedia of Social Science Research Methods. Thousand Oaks, CA: Sage, 876–868.
  39. QSR International Pty Ltd., 2017. NVivo Qualitative Data Analysis Software, Version 11. Melbourne, Australia: QSR International Pty Ltd.
  40. Ministry of Information and Communication Technology, 2000. The 2000 Population and Housing Census. Bangkok, Thailand: National Statistical Office.
  41. Waage J, 2010. The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre commission. Lancet 376: 9911023.
  42. Patcharanarumol W, Tangcharoensathien V, Limwattananon S, Panichkriangkrai W, Pachanee K, Poungkantha W, Gilson L, Mills A, , 2011. Why and how did Thailand achieve good health at low cost. Balabanova D, McKee M, Mills A, eds. Good Health at Low Cost’ 25 Years on What Makes a Successful Health System? London, United Kingdom: London School of Hygiene and Tropical Medicine, 193–223.
  43. Sumpradit N, 2017. New chapter in tackling antimicrobial resistance in Thailand. BMJ 358: j3415.
  44. So AD, Woodhouse W, , 2014. Thailand’s antibiotic smart use initiative. Bidgeli M, Peters DH, Wagner AK, eds. Medicines in Health Systems: Advancing Access, Affordability and Appropriate Use. Geneva, Switzerland: World Health Organization, 83–86.
  45. Department of Population, 2015. The 2014 Myanmar Population and Housing Census. Naypyidaw, Myanmar: Ministry of Immigration and Population.
  46. World Bank, 2017. The World Bank Data. Washington, DC: World Bank. Available at: https://data.worldbank.org. Accessed August 8, 2017.
  47. Ministry of Health and Sports, 2017. Myanmar National Health Plan 2017–2021. Naypyidaw, Myanmar: The Republic of the Union of Myanmar.
  48. Pannarunothai S, Patmasiriwat D, Srithamrongsawat S, , 2004. Universal health coverage in Thailand: ideas for reform and policy struggling. Health Policy 68: 1730.
  49. Skidmore M, , 2008. Contemporary medical pluralism in Burma. Skidmore M, Wilson T, eds. Dictatorship, Disorder and Decline in Myanmar. Canberra, Australia: ANU Press, 193–207.
  50. Holloway KA, Kotwani A, Batmanabane G, Puri M, Tisocki K, , 2017. Antibiotic use in south east Asia and policies to promote appropriate use: reports from country situational analyses. BMJ 358: j2291.
  51. Leventhal H, Weinman J, Leventhal EA, Phillips LA, , 2008. Health psychology: the search for pathways between behavior and health. Annu Rev Psychol 59: 477505.
  52. Staller KM, , 2010. Qualitative research. Salkind NJ, ed. Encyclopedia of Research Design. Thousand Oaks, CA: Sage, 1159–1163.
  53. Hennink M, Hutter I, Bailey A, , 2010. Qualitative Research Methods. London, United Kingdom: Sage.
  54. Mathison S, , 2005. Encyclopedia of Evaluation. Thousand Oaks, CA: Sage.
  55. Brieger WR, Salami KK, Oshiname FO, , 2007. Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria. Res Social Adm Pharm 3: 303319.
  56. Ansah EK, Reynolds J, Akanpigbiam S, Whitty CJ, Chandler CI, , 2013. “Even if the test result is negative, they should be able to tell us what is wrong with us”: a qualitative study of patient expectations of rapid diagnostic tests for malaria. Malar J 12: 258.
  57. Altaras R, Nuwa A, Agaba B, Streat E, Tibenderana JK, Strachan CE, , 2016. Why do health workers give anti-malarials to patients with negative rapid test results? A qualitative study at rural health facilities in western Uganda. Malar J 15: 23.
  58. Hutchinson E, Chandler C, Clarke S, Lal S, Magnussen P, Kayendeke M, Nabirye C, Kizito J, Mbonye A, , 2015. ‘It puts life in us and we feel big’: shifts in the local health care system during the introduction of rapid diagnostic tests for malaria into drug shops in Uganda. Crit Public Health 25: 4862.
  59. Kamat VR, , 2006. “I thought it was only ordinary fever!” cultural knowledge and the micropolitics of therapy seeking for childhood febrile illness in Tanzania. Soc Sci Med 62: 29452959.
  60. Hart JT, , 1971. The inverse care law. Lancet 297: 405412.

Data & Media loading...

  • Received : 21 Nov 2017
  • Accepted : 19 Jan 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error